China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd from Aerospace Shenzhou Biology & Technology Group Co., Ltd , China Aerospace Investment Holdings Ltd , China Spacesat Co.,Ltd. (SHSE:600118) and Beijing Dawn Aerospace Bio-tech Co., Ltd. for approximately CNY 500 million on August 1, 2022.Aerospace Shenzhou Biology & Technology Co., Ltd holds 21.88% of Shenzhou Biology & Technology Co., Ltd., 16.33% of Shenzhou Biology & Technology Co., Ltd. held by Aerospace Investment Holdings Co., Ltd, 8.33% of Shenzhou Biology & Technology Co., Ltd. by China Spacesat Co.,Ltd., and 3.57% of Shenzhou Biology & Technology Co., Ltd. by Beijing Dawn Aerospace Bio-tech Co., Ltd. This has been approved in the 18th Meeting of the Company's 9th Directorate held on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.27 CNY | +2.79% |
|
-7.61% | -21.49% |
Apr. 30 | China Spacesat Swings to Q1 Loss as Operating Income Plunges 75% | MT |
Apr. 29 | China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
20.27 CNY | +2.79% | -7.61% | 3.2B | ||
18.13 CNY | +2.03% | -3.51% | 2.49B | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.49% | 3.2B | |
+15.12% | 34.3B | |
+49.02% | 4.62B | |
-1.35% | 2.28B | |
+32.71% | 1.55B | |
+27.23% | 568M | |
+86.67% | 519M | |
-20.65% | 515M | |
+69.31% | 394M | |
-64.85% | 378M |
- Stock Market
- Equities
- 600118 Stock
- News China Spacesat Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd. for approximately CNY 500 million.